increased from 15.7% to 15.8%. The margin development was mainly influenced by the favorable development of pharmaceutical costs and the negative effects of the implementation of the new Medicare end-stage renal disease prospective payment system in the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Fresenius Medical Care Reports Strong Start For 2011 And Raises Guidance For Full Year 2011
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account